Monoamine oxidases, type A and type B, are principal MAO-A in human disease through the use of genomic enzymes for the degradation of biogenic amines, DNA, which is more accessible than the RNA, as a including catecholamines and serotonin. These template for PCR-amplification and sequencing. isozymes have been implicated in neuropsychiatric disorders. Previously, cDNA clones for both MAO-A INTRODUCTION and MAO-B have been sequenced and the genes encoding them have been localized to human Monoamine oxidases (MAO; monoamine: 02 oxidoreductase; chromosome Xp11.23-Xp11.4. In this work, we EC1.4.3.4.), type A and type B, are principal enzymes for the isolated human genomic clones spanning almost all the degradation of biogenic amines, (for review see 1,2,3). They MAOA gene from cosmid and phage libraries using a catalyze the oxidative deamination of amine neurotransmitters cDNA probe for MAO-A. Restriction mapping and such as dopamine, norepinephrine, epinephrine and serotonin, sequencing show that the human MAOA gene extends as well as dietary amines such as tryptamine and over 70 kb and is composed of 15 exons. The exon phenylethylamine. These enzymes are located in the outer structure of human MAOA is similar to that described membrane of mitochondria and are present in all types of cells, by others for human MAOB. Exon 12 (bearing the albeit at widely varying levels. Intensive biochemical and codon for cysteine, which carries the covalently bound pharmacological studies of MAO have been stimulated from FAD cofactor) and exon 13 are highly conserved findings that inhibitors of the enzymes can be used as between human MAOA and MAOB genes (92% at the antidepressants (4). These studies have led to the characterization amino acid level). Earlier work revealed two species of of two forms of the enzyme, MAO-A and MAO-B, which differ MAO-A mRNA, 2.1 kb and 4.5 -5.5 kb. We now report in specificity for substrates, sensitivity to inhibitors, tissue on further cDNA isolation and sequencing, which distribution, antigenic determinants, protein size and peptide maps demonstrates that the longer message has an (for review see 1, 2, 3). It is now clear from cDNA clones that extension of 2.2 kb in the 3' noncoding region. This these MAO isozymes are encoded by separate genes, which share extended region is contained entirely within exon 15. about 70% overall homology in amino acid sequence (5-9). The two messages therefore appear to be generated Both human MAO genes have been mapped to the chromosome by the use of two alternative polyadenylation sites. X in the pl 1.23 -11.4 region (10) (11) (12) (13) (14) . Absence of both genes Results from the present work should facilitate the has been described in atypical, male Norrie disease patients from mutational analysis of functional domains of MAO-A four different families, who have a submicroscopic deletion in and MAO-B. Knowledge of the gene structure will also this region of the X chromosome (13, 15-18; Z.Chen and help in evaluating the role of genetic variations in I.Craig, unpublished data; F.Collins and S.Antonarakis,
manuscript submitted). It is conceivable that some features of their disease phenotype, such as microcephaly, mental retardation, seizures, and sleep disturbances, may result from the complete absence of MAO enzymatic activities in these patients throughout development and in later life. Other studies have shown that variant activities of platelet MAO-B are statistically associated with a number of neuropsychiatric diseases including affective disorders (19, 20) , schizophrenia (21) and alcoholism (22, 23) . A potential role of MAO in diseases of the nervous system is further suggested by findings that MAO-B can convert MPTP into a neurotoxin that causes neurodegeneration similar to Parkinson disease (24) . In addition, deprenyl, an inhibitor of MAO-B, appears to be effective in slowing down the progression of Parkinson disease (25, 26) . Allele association studies of MAO-A indicate that genetic variations at the structural locus are major determinants of activity levels in human skin fibroblasts (27) . The structure of the human MAOA gene is reported here as a basis for studying the regulation of enzyme activity and its etiological role in human diseases.
MATERIAL AND METHODS
Isolation of genomic DNA and cDNA clones Genomic clone A2 was isolated from a cosmid library prepared from a Sau IA partial digest of human genomic DNA (gift from Dr. Patricia Watkins, Integrated Genetics, Framingham, MA) established in the vector c2XB (28) . A full length human cDNA clone for MAO-A, HMl 1 (6) 
RESULTS
We have isolated genomic clones from three libraries (see Material and Methods). Clones 6.12, common, 4.15, 1.23 and 6.1 are from a phage library and cover most of the MAOA gene. All clones, together with those isolated from other libraries, including A2, gMAO-Al and 5-SC were aligned to yield a region for MAOA covering about 70 kb. These clones were analyzed by Southern analysis of restriction digests using various fragments from the cDNA, HMl 1, as probes. Detailed alignment was done by superimposition of restriction sites for EcoRI, HindHI, BglII and Sail. A composite restriction map for these enzymes is shown in Figure 1 . Exon 1 contains 5'-noncoding sequences corresponding to the cDNA clone hMAO A-7 (5) (Figure 2 ). The 5' end of the first exon has not been defined precisely, but a potential TATA box appears 194 bp from the 5' end of the published cDNA sequence, which may serve as a promoter element. A comparison between the two published cDNA sequences, HMl 1 (6) found in genomic clones (Figure 2 ), it appears those in HM1 are a cloning artifact. We have determined the exon structure of MAOA by two approaches. (A) Genomic clones were subcloned into sequencing vectors and sequenced. (B) Genomic DNA fragments were amplified using the polymerase chain reaction with appropriate primers from the cDNA sequence to generate DNA segments for direct sequencing. The latter approach was feasible only for segments containing exons and introns totalling less than 3 kb. The structure of the exons and nucleotide sequences near the intron/exon junctions are shown in figure 3 . All exon-intron junctions showed appropriate consensus signals for splicing; GT at the 5 (44) . It is therefore of interest that activity levels in human females are consistently higher (about 20%) than those observed in males (45) . There is the possibility that the MAO gene(s) are not completely inactivated on the inactive X in female cells, as other loci in this region of Xp have been found to resist this inactivation (46) .
The MAOB gene is also divided into 15 exons with identical exon boundaries, at least for exons [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] (43) . Both nucleotide and amino acid sequences of the exons corresponding to the coding regions of the cDNAs for the two genes show extensive homology (5, 6) . Similarities in amino acids for exon [1] through [15] are: 60% [1] , 72% [2] , 74% [3] , 77% [4] , 70% [5] , 75% [6] , 74% [7] , 68% [8] , 66% [9] , 67% [10] , 80% [11] , 94% [12] , 89% [13] , 48% [14] , and 60% [15] . Exons (12, 17) , MspI (51) and Fnu4HI (27) . In addition, an informative (CA)n repeat polymorphism has been described within the MAOA gene (52) . Using RFLP analysis of DNA from 40 males whose MAO-A activity measured in cultured skin fibroblasts varied over 200-fold, a strong correlation was observed between allelic status and activity level (27) , indicating that the structural locus is a strong determinant of activity levels.
There is clearly much to be learned at a variety of levels concerning the relationship between the two forms of the enzyme and in the differences and similarities in their functional domains. The elucidation of their detailed genomic organization also provides a basis for exploring variations in gene structure associated with disease states.
Note. All intronic sequences obtained during this analysis, as well as the 3' sequences for the longer form of the MAO-A mRNA encoded in exon 15, have been deposited in EMBL (accession nos X60517 -X60541). Following review of this paper, another paper was published describing the exon structure of the human MAOA gene (Grimsby et al, 1991) . These two papers agree exactly on exon structure, with minor differences in intron sequences, which may reflect polymorphisms.
